Jardiance Tablets (generic name: empagliflozin) is a drug that inhibits SGLT2 (sodium-glucose coupled transport carrier 2).
By inhibiting SGLT2 and suppressing sugar reabsorption, this medicine promotes sugar excretion into the urine and lowers blood sugar levels.
Empagliflozin is used to treat type 2 diabetes.
Empagliflozin is said to be a sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor.
SGLT2 is a protein that works in the renal tubules of the kidney.
The kidneys have the role of reabsorbing sugar from urine and returning it to the body.
However, inhibiting SGLT2 reduces glucose reabsorption in the kidney,
As a result, the amount of sugar excreted in the urine increases.
It has the effect of lowering blood sugar levels because it increases the amount of sugar excreted in the urine.
This effect is thought to lead to weight loss because calories are lost through sugar excreted in the urine.
Reference: MEDICATION GUIDE JARDIANCE / Boehringer Ingelheim
By suppressing the action of SGLT2, Jardiance promotes the excretion of sugar from the blood into the urine and lowers blood sugar.
As a result, the excess sugar you ingest is thrown out of your body along with your urine.
Therefore, it is a drug that can be expected to have a dieting effect without reducing appetite, that is, without restricting diet.
There are two types of Jardiance tablets available at our hospital: 10mg and 25mg.
Each medicine has a different strength of action, and 25 mg can cut more carbohydrates.
It is possible to prescribe a dosage that is tailored to the individual based on their daily eating habits and side effects.
Please feel free to contact us.